This test uses a radioactive substance to create pictures of blood vessels in your body. It helps doctors see if there are blockages or other problems in arteries or veins. It's a way to visualize blood flow within vessels.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Radioisotope angiography is a nuclear medicine scan that follows a small amount of radioactive tracer through the bloodstream to show how an organ is working. Today the term almost always refers to a heart scan often called a multigated acquisition (MUGA) scan or radionuclide ventriculography. The tracer is attached to your own red blood cells, and a special camera records the blood moving in and out of the heart's chambers with each beat. The main result is the ejection fraction: the share of blood the left ventricle, the heart's main pumping chamber, pushes out with each beat. A value of about 50% or higher is generally considered normal. A lower number means the heart is pumping less strongly, and the scan can also show whether one part of the heart wall is moving poorly, which can point to damage from a past heart attack. The most common reason for the scan is cancer treatment. Some chemotherapy and targeted medicines, such as anthracyclines and trastuzumab (Herceptin), can weaken the heart, so the care team measures pumping strength before treatment starts and repeats it during and after treatment. It is also used to assess heart failure, cardiomyopathy (disease of the heart muscle), valve disease and coronary artery disease, and sometimes before a transplant or in a research study. An echocardiogram, an ultrasound of the heart, is usually the first choice for measuring pumping function because it involves no radiation. A MUGA scan is used when ultrasound images are hard to obtain, for example after chest wall surgery, when an echocardiogram is not available, or when very consistent repeat measurements are wanted. Cardiac magnetic resonance imaging (MRI) is another alternative. This scan does not show the coronary arteries or pinpoint blockages the way a catheter angiogram or a computed tomography (CT) coronary angiogram does, and it is different from a nuclear stress test, which looks at blood flow to the heart muscle.
Preparation is usually simple. Some centers ask you not to eat or drink for a few hours beforehand, while others need no special preparation, so follow the instructions you are given. Wear comfortable clothing, and allow time beyond the scan itself: the tracer preparation and imaging together usually take more than an hour. Tell the team ahead of time if there is any chance you are pregnant or if you are breastfeeding, because the scan involves radiation. Also mention a heparin allergy or heparin-induced thrombocytopenia, a past reaction to the blood thinner heparin, so the center can plan how it prepares the tracer. Let them know if lying flat on your back for 45 minutes or more would be difficult.
A technologist first places an IV, a thin tube in a vein, usually in the arm, or uses an existing port or central line. In a common method, a small blood sample is drawn and the red blood cells are labeled with a tracer called technetium-99m, which takes about 20 to 30 minutes. The labeled cells are returned through the vein, and the injection itself is usually painless apart from the needle. You lie on your back while a camera is positioned over your chest. Small sticky patches called electrodes record your heart rhythm with an electrocardiogram (ECG), and the camera times its pictures to each heartbeat. A computer combines many beats into a moving picture of the heart pumping. The camera takes views from a few angles, and imaging typically takes around 45 minutes. You need to stay still, but no sedation is used and you are awake throughout.
There is no recovery period. Most people go back to normal activities, including driving, as soon as the scan is finished. The needle site may be a little sore or red briefly. The tracer loses its radioactivity over hours to days and leaves the body mostly in urine, and drinking fluids helps it pass. A doctor trained in nuclear medicine or cardiology reviews the images and sends a report to the clinician who ordered the test. If you are being monitored during cancer treatment, the key question is usually whether your ejection fraction has fallen compared with earlier scans. A meaningful drop may lead the team to pause or change a treatment, start heart-protective medicines or involve a cardiologist, so ask when and how you will hear the results.
This is a low-risk test. The main consideration is radiation: the tracer gives a small dose that is considered acceptable for diagnosis, with no known long-term effects at this level. Because doses add up, a scan repeated many times, as in monitoring during long cancer treatment, is one reason teams often prefer echocardiography when it gives reliable images. Allergic reactions to the tracer are extremely rare and usually mild. The injection can cause brief discomfort, redness or a small bruise. Pregnancy calls for a discussion of whether the scan is needed now or whether another test would serve. The scan's main limitation is what it measures: it describes pumping function, not the cause, so an abnormal result often leads to further tests.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Radioisotope Angiography, what to expect, or ask the community a question.